Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Trichard, C. Articles by Martinot, J.-L. Search for Related Content PubMed Citation Articles by Trichard, C. Articles by Martinot, J.-L.

Binding of Antipsychotic Drugs to Cortical 5-HT_2A Receptors: A PET Study of Chlorpromazine, Clozapine, and Amisulpride in Schizophrenic Patients

OBJECTIVE: This study examined the binding to cortical serotonin 5-HT_2A receptors of conventional doses of the typical neuroleptic chlorpromazine in comparison with clozapine, the prototype atypical antipsychotic, and amisulpride, a specific dopamine D₂-D₃ blocker. METHOD: Seventeen schizophrenic patients treated with chlorpromazine (75–700 mg/day), four treated with clozapine (200–600 mg/day), and five treated with amisulpride (200–1200 mg/day) were studied. Cortical 5-HT_2A binding was estimated by reference to the values for 14 antipsychotic-free schizophrenic subjects with the use of positron emission tomography and [¹⁸F]setoperone, a high-affinity radioligand for cortical 5-HT_2A receptors. RESULTS: A dose-dependent decrease in the number of available cortical binding sites for [¹⁸F]setoperone was demonstrated in the chlorpromazine group; for the highest dose, there was a virtual lack of sites available for binding. A very low percentage of available binding sites was also observed in the clozapine-treated patients at all doses. This suggests a high level of 5-HT_2A blockade with both clozapine and high doses of chlorpromazine. No significant binding of amisulpride to 5-HT_2A receptors was detected. CONCLUSIONS: A high level of 5-HT_2A receptor blockade does not appear specific to clozapine in comparison with high doses of chlorpromazine, suggesting that the distinct clinical profiles of both drugs are unrelated to 5-HT_2A blockade itself.

This article has been cited by other articles:

				J. M. Stone, J. M. Davis, S. Leucht, and L. S. Pilowsky Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs--An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Literature Schizophr Bull, February 26, 2008; (2008) sbn009v1. [Abstract] [Full Text] [PDF]

				G. P. Reynolds Receptor Mechanisms in the treatment of Schizophrenia J Psychopharmacol, September 1, 2004; 18(3): 340 - 345. [Abstract] [PDF]

				P. Seeman Atypical Antipsychotics: Mechanism of Action Focus, January 1, 2004; 2(1): 48 - 58. [Abstract] [Full Text] [PDF]

				R. A. Bressan, K. Erlandsson, H. M. Jones, R. Mulligan, R. J. Flanagan, P. J. Ell, and L. S. Pilowsky Is Regionally Selective D2/D3 Dopamine Occupancy Sufficient for Atypical Antipsychotic Effect? An In Vivo Quantitative [123I]Epidepride SPET Study of Amisulpride-Treated Patients Am J Psychiatry, August 1, 2003; 160(8): 1413 - 1420. [Abstract] [Full Text] [PDF]

				S. Kapur and P. Seeman Does Fast Dissociation From the Dopamine D2 Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis Am J Psychiatry, March 1, 2001; 158(3): 360 - 369. [Abstract] [Full Text]

				L. N. Yatham, P. F. Liddle, J. Dennie, I-S. Shiah, M. J. Adam, C. J. Lane, R. W. Lam, and T. J. Ruth Decrease in Brain Serotonin 2 Receptor Binding in Patients With Major Depression Following Desipramine Treatment: A Positron Emission Tomography Study With Fluorine-18-Labeled Setoperone Arch Gen Psychiatry, August 1, 1999; 56(8): 705 - 711. [Abstract] [Full Text] [PDF]

				S. Kapur, R. B. Zipursky, and G. Remington Clinical and Theoretical Implications of 5-HT2 and D2 Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in Schizophrenia Am J Psychiatry, February 1, 1999; 156(2): 286 - 293. [Abstract] [Full Text]

				What Does 5-HT2A Receptor Blockade Add to Clozapine's Effectiveness? Journal Watch Psychiatry, June 1, 1998; 1998(601): 11 - 11. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us